These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 27654152)
1. A comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers. Katalinić M; Maček Hrvat N; Baumann K; Morasi Piperčić S; Makarić S; Tomić S; Jović O; Hrenar T; Miličević A; Jelić D; Žunec S; Primožič I; Kovarik Z Toxicol Appl Pharmacol; 2016 Nov; 310():195-204. PubMed ID: 27654152 [TBL] [Abstract][Full Text] [Related]
2. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase. Bartling A; Worek F; Szinicz L; Thiermann H Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809 [TBL] [Abstract][Full Text] [Related]
3. Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes. Zorbaz T; Malinak D; Kuca K; Musilek K; Kovarik Z Chem Biol Interact; 2019 Jul; 307():16-20. PubMed ID: 31004594 [TBL] [Abstract][Full Text] [Related]
4. Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes. Nichols RH; Chambers JE Toxicology; 2021 Mar; 452():152719. PubMed ID: 33592259 [TBL] [Abstract][Full Text] [Related]
5. Targeting organophosphorus compounds poisoning by novel quinuclidine-3 oximes: development of butyrylcholinesterase-based bioscavengers. Zandona A; Katalinić M; Šinko G; Radman Kastelic A; Primožič I; Kovarik Z Arch Toxicol; 2020 Sep; 94(9):3157-3171. PubMed ID: 32583098 [TBL] [Abstract][Full Text] [Related]
6. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122 [TBL] [Abstract][Full Text] [Related]
7. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro. Jun D; Musilova L; Kuca K; Kassa J; Bajgar J Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161 [TBL] [Abstract][Full Text] [Related]
8. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953 [TBL] [Abstract][Full Text] [Related]
9. Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase. Kovarik Z; Katalinić M; Sinko G; Binder J; Holas O; Jung YS; Musilova L; Jun D; Kuca K Chem Biol Interact; 2010 Sep; 187(1-3):167-71. PubMed ID: 20206154 [TBL] [Abstract][Full Text] [Related]
10. Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase. Horn G; Wille T; Musilek K; Kuca K; Thiermann H; Worek F Arch Toxicol; 2015 Mar; 89(3):405-14. PubMed ID: 24912784 [TBL] [Abstract][Full Text] [Related]
11. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study. Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245 [TBL] [Abstract][Full Text] [Related]
12. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds. Bušić V; Katalinić M; Šinko G; Kovarik Z; Gašo-Sokač D Toxicol Lett; 2016 Nov; 262():114-122. PubMed ID: 27693733 [TBL] [Abstract][Full Text] [Related]